Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /APLLTD
chevron_leftBack

Alembic Pharmaceuticals Ltd.

APLLTD
NSE: APLLTD Delayed
883.80INR 3.3%
10.34 USD
As of 24 April 2025, Alembic Pharmaceuticals Ltd. has a market cap of $1.97B USD, ranking #5380 globally and #374 in India. It ranks #490 in the Healthcare sector, and #100 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
5380
Country Rank
374
Sector Rank
490
Industry Rank
100
Key Stats
Market Cap
$1.97BUSD
168.22B INR
Enterprise Value
$2.08BUSD
177.59B INR
Revenue (TTM)
$752.3MUSD
64.19B INR
EBITDA (TTM)
$113.09MUSD
9.67B INR
Net Income (TTM)
$70.87MUSD
6.05B INR
EBITDA Margin
15%
Profit Margin
9.4%
PE Ratio
27.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Chirayu Amin open_in_new
Employees
14,858
Founded
1907
Website
alembicpharmaceuticals.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.3% 1.1% -10% -17% -25% -8.8%
Upcoming Earnings
Earnings Date
Thu, May 8

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
APLLTD
Alembic Pharmaceuticals Ltd
ISIN: INE901L01018
Shares Out.:
196.563M1 Shares Float: 58.746M2
TV:
SA:
YF:
GF:
BA:
MS:
883.80 INR
Bombay Stock Exchange
MIC: XBOM
533573 (APLLTD)
Alembic Pharmaceuticals Ltd
ISIN: INE901L01018
TV:
SA:
YF:
GF:
BA:
MS:
850.25 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. The company was founded in 1907 and is headquartered in Vadodara, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
2K%
Divi's Laboratories Ltd.
DIVISLAB
$18.39B
1.57T INR
833%
Cipla Ltd.
CIPLA
$14.46B
1.23T INR
634%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.23B
1.13T INR
571%
Mankind Pharma Ltd.
MANKIND
$12.47B
1.06T INR
533%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
3K%
Merck KGaA
MRK
$59.42B
52.43B EUR
3K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
2K%
Haleon plc
HLN
$45.57B
34.34B GBP
2K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
1K%